Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models

Por Alexander Cecil, Ivaylo Gentschev, Marion Adelfinger, Thomas Dandekar, Aladar A. Szalay
Publicado em 2019-01-01

Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.

Por Ulrike Donat, Stephanie Weibel, Michael Hess, Jochen Stritzker, Barbara Härtl, Julia B Sturm, Nanhai G Chen, Ivaylo Gentschev, Aladar A Szalay
Publicado em 2012-01-01

Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy

Por Dana Haddad, Nicholas Socci, Chun-Hao Chen, Nanhai G Chen, Qian Zhang, Susanne G Carpenter, Arjun Mittra, Aladar A Szalay, Yuman Fong
Publicado em 2016-01-01

Regression of Human Prostate Tumors and Metastases in Nude Mice following Treatment with the Recombinant Oncolytic Vaccinia Virus GLV-1h68

Por Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, Stephanie Weibel, Marion Adelfinger, Viktoria Raab, Martin Heisig, Nanhai Chen, Yong A. Yu, Jochen Stritzker, Aladar A. Szalay
Publicado em 2010-01-01

Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers

Por Dobrin D. Draganov, Antonio F. Santidrian, Ivelina Minev, Duong Nguyen, Mehmet Okyay Kilinc, Ivan Petrov, Anna Vyalkova, Elliot Lander, Mark Berman, Boris Minev, Aladar A. Szalay
Publicado em 2019-03-01

First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells

Por Boris R. Minev, Elliot Lander, John F. Feller, Mark Berman, Bernadette M. Greenwood, Ivelina Minev, Antonio F. Santidrian, Duong Nguyen, Dobrin Draganov, Mehmet O. Killinc, Anna Vyalkova, Santosh Kesari, Edward McClay, Gabriel Carabulea, Francesco M. Marincola, Lisa H. Butterfield, Aladar A. Szalay
Publicado em 2019-08-01